Gene expression profiling in lymph node-positive and lymph node-negative pancreatic cancer.

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Pancreatic cancer is a highly aggressive malignancy with poor prognosis.
• Lymph node metastasis is a critical factor influencing patient survival and treatment strategies.

Purpose of the Study:

• To identify genes associated with lymph node metastasis in pancreatic cancer.
• To compare gene expression profiles between metastatic and non-metastatic pancreatic tumors.
• To predict cancer invasiveness and progression based on identified gene expression patterns.

Main Methods:

• Gene expression profiling using DNA microarray (37,842 genes) on 10 pancreatic cancer tissue specimens.
• Differential gene expression analysis (≥1.5-fold change) in at least 5 sample pairs.
• Two-way clustering for sample and gene classification.
• Validation of screened genes using real-time polymerase chain reaction.

Main Results:

• Identified 194 differentially expressed genes (66 overexpressed, 128 underexpressed) in lymph node-positive pancreatic cancer.
• Key genes identified include oncogenes, tumor suppressor genes, apoptosis regulators, angiogenesis factors, and cell cycle regulators.
• Genes promoting tumor cell growth were upregulated, while apoptosis-inducing genes were downregulated in metastatic tumors.

Conclusions:

• Discovery of novel genes potentially involved in pancreatic cancer metastasis and patient survival.
• Provides new insights into the mechanisms of pancreatic cancer lymph node metastasis.
• Potential for improved early diagnosis and development of innovative therapeutic strategies for pancreatic cancer.